Tempero-spatial dissociation between the expression of Fas and apoptosis after coronary occlusion

Journal of Clinical Pathology - Molecular Pathology

Volumn 56, Issue 6, 2003, Pages 362-367

  Feng, Q Z ^a   Li, T D ^a   Wei, L X ^b   Qiao, X ^b   Yi, J ^a   Wang, L ^a   Yang, T S ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b GENERAL HOSPITAL OF PEOPLE'S LIBERATION ARMY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL SYNCHRONIZATION; CONTROLLED STUDY; DISSOCIATION; HEART HYPERTROPHY; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HISTOPATHOLOGY; LEFT CORONARY ARTERY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; BIOLOGICAL MARKERS; BLOTTING, WESTERN; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MALE; MODELS, ANIMAL; MYOCARDIAL ISCHEMIA; MYOCARDIUM; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 0348134962     PISSN: 13668714     EISSN: None     Source Type: Journal    
DOI: 10.1136/mp.56.6.362     Document Type: Article

References (31)

1. Bialik S, Geenen DL, Sasson IE, et al. Myocyte apoptosis during acute myocardial infarction in the mouse localizes to hypoxic regions but occurs independently of p53. J Clin Invest 1997;100:1363-72.
2. Cheng W, Kajstura J, Nitahara JA, et al. Programmed myocyte cell death affects the viable myocardium after infarction in rats. Exp Cell Res 1996;226:316-27.
3. Fliss H, Gattinger D. Apoptosis in ischemic and reperfused rat myocardium. Circ Res 1996;79:949-56.
4. Narula J, Haider N, Virmani R, et al. Apoptosis in myocytes in end-stage heart failure. N Engl J Med 1996;335:1182-9.
5. Olivetti G, Quaini F, Sala R, et al. Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart. J Mol Cell Cardiol 1996;28:2005-16.
6. Kajstura J, Cheng W, Reiss K, et al. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest 1996;74:86-107.
7. Saraste A, Pulkki K, Kallajoki M, et al. Apoptosis in human acute myocardial infarction. Circulation 1997;95:320-3.
8. Gottlieb RA, Burleson KO, Kloner RA, et al. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 1994;94:1621-8.
9. Olivetti G, Abbi R, Quaini F, et al. Apoptosis in the failing human heart. N Engl J Med 1997;336:1131-41.
10. Teiger E, Than VD, Richard L, et al. Apoptosis in pressure overload-induced heart hypertrophy in the rat. J Clin Invest 1996;97:2891-7.
11. Chen Z, Chua CC, Ho YS, et al. Overexpression of Bcl-2 attenuates apoptosis and protects against myocardial I/R injury in transgenic mice. Am J Physiol Heart Circ Physiol 2001;280:H2313-20.
12. Yaoita H, Ogawa K, Maehara K, et al. Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor. Circulation 1998;97:276-81.
13. Holly TA, Drincic A, Byun Y, et al. Caspase inhibition reduces myocyte cell death induced by myocardial ischemia and reperfusion in vivo. J Mol Cell Cardiol 1999;31:1709-15.
14. Brocheriou V, Hagege AA, Oubenaissa A, et al. Cardiac functional improvement by a human Bcl-2 transgene in a mouse model of ischemia/reperfusion injury. J Gene Med 2000;2:326-33.
15. Jeremias I, Kupatt C, Martin-Villalba A, et al. Involvement of CD95/Apo1/ Fas in cell death after myocardial ischemia. Circulation 2000;102:915-20.
16. Tanaka M, Ito H, Adachi S, et al. Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes. Circ Res 1994;75:426-33.
17. Wollert KC, Heineke J, Westermann J, et al. The cardiac Fas (APO-1/CD95) receptor/Fas ligand system: relation to diastolic wall stress in volume-overload hypertrophy in vivo and activation of the transcription factor AP-1 in cardiac myocytes. Circulation 2000;101:1172-8.
18. Yue TL, Ma XL, Wang X, et al. Possible involvement of stress-activated protein kinase signaling pathway and Fas receptor expression in prevention of ischemia/reperfusion-induced cardiomyocyte apoptosis by carvedilol. Circ Res 1998;82:166-74.
19. Nakamura T, Ueda Y, Juan Y, et al. Fas-mediated apoptosis in adriamycin-induced cardiomyopathy in rats: in vivo study. Circulation 2000;102:572-8.
20. Nagata S, Suda T. Fas and Fas ligand: Ipr and gld mutations. Immunol Today 1995;16:39-43.
21. Yang J, Jones SP, Suhara T, et al. Endothelial cell overexpression of fas ligand attenuates ischemia-reperfusion injury in the heart. J Biol Chem 2003;278:15185-91.
22. Badorff C, Ruetten H, Mueller S, et al. Fas receptor signaling inhibits glycogen synthase kinase 3 beta and induces cardiac hypertrophy following pressure overload. J Clin Invest 2002;109:373-81.
23. Nelson DP, Setser E, Hall DG, et al. Proinflammatory consequences of transgenic fas ligand expression in the heart. J Clin Invest 2000;105:1199-208.
24. Budd RC. Death receptors couple to both cell proliferation and apoptosis. J Clin Invest 2002;109:437-41.
25. Wajant H. The Fas signaling pathway: more than a paradigm. Science 2002;296:1635-6.
26. Nagata S, Golstein P. The Fas death factor. Science 1995;267:1449-56.
27. Ashkenazi A, Dixit VM. Death receptors: signaling and modulation. Science 1998;281:1305-8.
28. Selye H, Bajusz E, Grasso S, et al. Simple techniques for the surgical occlusion of coronary vessels in the rat. Angiology 1960;11:389-407.
29. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992;119:493-501.
30. Krajewski S, Krajewska M, Shabaik A, et al. Immunohistochemical determination of in vivo distribution of Box, a dominant inhibitor of Bcl-2. Am J Pathol 1994;145:1323-36.
31. Leri A, Claudio PP, Li Q, et al. Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renninangiotensin system and decreases the Bcl-2-to-Bax protein ratio in the cell. J Clin Invest 1998;101:1326-42.